Form 4: Clorox CFO Reports Stock Vesting & Tax Withholding

Sentiment:

Insider Transaction Report


Clorox EVP and CFO Luc Bellet reported the vesting of performance units and subsequent tax-related stock withholdings on October 3, 2025.

Summary

  • Luc Bellet, EVP Chief Financial Officer of Clorox Co, reported transactions involving common stock.
  • On October 3, 2025, 2,581 shares were acquired at $122.25 per share due to the settlement of a 2022 Performance Unit Grant that vested on the same date.
  • Concurrently, 421 shares were disposed of at $122.25 per share to satisfy tax obligations related to the vesting of restricted stock.
  • An additional 893 shares were disposed of at $122.25 per share to satisfy tax obligations related to the vesting of performance stock units.
  • Following these transactions, Luc Bellet beneficially owns 20,864 shares of Clorox common stock, which includes 167 shares acquired via a dividend reinvestment feature.

Sentiment

Score: 5

Explanation: The filing reports routine executive compensation transactions (vesting and tax withholding) which are neutral in terms of company performance or outlook.

Positives

  • The vesting of 2,581 performance units indicates the achievement of performance targets, leading to executive compensation for Luc Bellet.
  • The inclusion of 167 shares from a dividend reinvestment feature demonstrates ongoing participation in the company's stock incentive plan.

Negatives

  • A total of 1,314 shares were withheld by the company to cover tax obligations, reducing the net shares received by the executive.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This routine insider transaction filing does not provide information relevant to broader industry trends or competitive analysis.

Comparison to Industry Standards

  • This filing details standard executive compensation practices involving performance unit vesting and tax withholding, which are common across publicly traded companies. No specific comparable companies or projects are mentioned.

Stakeholder Impact

  • Shareholders: Minimal direct impact as these are routine, pre-scheduled executive compensation events.
  • Employees: No direct impact mentioned.
  • Customers: No direct impact mentioned.
  • Suppliers: No direct impact mentioned.
  • Creditors: No direct impact mentioned.

Key Dates

DateDescription
10/03/2025Date of earliest transaction, including vesting of 2022 Performance Unit Grant and related stock acquisitions/dispositions.
10/07/2025Signature date of the reporting person's attorney-in-fact.

Keywords

Clorox, CLX, Form 4, insider transaction, executive compensation, stock vesting, tax withholding, Luc Bellet

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.